Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001356027 | SCV001551081 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The ABCB4 p.Ile637Asn variant was not identified in the literature nor was it identified in ClinVar, Cosmic, or LOVD 3.0. The variant was identified in dbSNP (ID: rs202167250) and in control databases in 32 of 281814 chromosomes at a frequency of 0.0001136 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 16 of 30598 chromosomes (freq: 0.000523), Other in 1 of 7190 chromosomes (freq: 0.000139), European (non-Finnish) in 14 of 128404 chromosomes (freq: 0.000109) and Latino in 1 of 35400 chromosomes (freq: 0.000028), but was not observed in the African, Ashkenazi Jewish, East Asian, and European (Finnish) populations. The variant occurs outside of the splicing consensus sequence and in silico splicing prediction programs (SpliceSiteFinder-like, NNSPLICE, MaxEntScan and GeneSplicer) do not predict a greater than 10% difference in splicing. The p.Ile637 residue is not conserved in mammals and four of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |